Feature | May 15, 2017

Expert Consensus on MRI and Radiation Exposure in Patients With Implantable Cardiac Electronic Devices

At Heart Rhythm 2017, a panel of experts from 11 international organizations share recommendations for health care providers and patient populations exposed to MRI and radiation

HRS released a consensus statement on MRI for patients with cardiac implantable electronic devices

May 15, 2017 — The Heart Rhythm Society (HRS) released a first-of-its-kind consensus statement in the United States on indications of patients who undergo magnetic resonance imaging (MRI) and radiation exposure with cardiovascular implantable electronic devices (CIEDs). The expert writing group presented the recommendations included in the “2017 HRS Expert Consensus Statement on Magnetic Resonance Imaging and Radiation Exposure in Patients with Cardiovascular Implantable Electronic Devices” at Heart Rhythm 2017, the Heart Rhythm Society’s 38th Annual Scientific Sessions.

There is an increasing number of people with CIEDs, and approximately 200,000 pacemakers are implanted in the United States each year.[1] Historically, MRI scanning and radiation exposure for patients with CIEDs has prompted concerns due to their unpredictable effects and interferences in safely and the overall function of the devices. Recent studies have suggested that MRI can be done safely in many patients with magnetic resonance (MR) conditional and nonconditional systems.

The expert consensus statement is intended to help frontline cardiologists, radiologists, radiation oncologists, and other health care professionals involved in the care of adult and pediatric patients with CIEDs. To further address the issue, the expert writing group also discusses the safety of employees with CIEDs who may come into an MRI environment. 

The document provides guidance on who would be suitable to undergo certain procedures and how to monitor the individuals who are exposed to:
• MRI
• Radiation exposure for CT scans
• Cancer treatment with radiation

“Oftentimes, healthcare providers may recommend removing a device before being exposed to radiation for cancer treatments because of existing safety concerns, but the removal of the device itself could pose risks to the patient,” says Julia Indik, M.D., Ph.D., professor of medicine and director of cardiovascular disease fellowship program at the University of Arizona, Sarver Heart Center. “We hope that our recommendations will make decisions easier for clinicians and ensure we are delivering optimal patient care while setting the first-ever standard of individualized protocols for patients with these devices.”

Access the full consensus statement document 

The statement includes specific recommendations in the following subsections:
• Introduction and Methodology
• Definitions of CIED Systems in Relation to MRI
• MRI Technology and Relationship to Risk
• MR Conditional CIED Technology
• Management of the CIED Patient Referred for MRI
• Management of the CIED Patient Undergoing CT Imaging
• Management of the CIED Patient Undergoing Radiation Therapy
• Future Directions

The members of the expert writing group performed a comprehensive electronic literature search and then developed a series of recommendations. This was done from randomized controlled trials, nonrandomized observational studies, and case series to support useful and practical recommendations, given that each individual institution serves its patient population uniquely. The writing group also evaluated computational modeling and in vitro and animal studies to explore and identify specific combinations that may pose a higher risk to patients, which cannot be determined by clinical studies alone.

The expert consensus statement was developed in collaboration with 11 international organizations: American Heart Association (AHA), American College of Cardiology (ACC), American College of Radiology (ACR), Asia Pacific Heart Rhythm Society (APHRS), American Society for Radiation Oncology (ASTRO), Council of Affiliated Regional Radiation Oncology Societies (CARROS), European Heart Rhythm Association (EHRA), Japanese Heart Rhythm Society (JHRS), Pediatric and Congenital Electrophysiology Society (PACES), Sociedade Brasileira de Arritmias Cardíacas (SOBRAC), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

The document was also published today in the online edition of HeartRhythm, the official journal of the Heart Rhythm Society. To review the full document, click here.
 

For more information: www.hrssessions.org

 

Reference:

1. Van Der Zee SA, Doshi SK. Permanent leadless cardiac pacing. Available at http://www.acc.org/latest-in-cardiology/articles/2016/03/23/08/09/permanent-leadless-cardiac-pacing.

Related Content

Lantheus and GE Healthcare Sign Agreement for Worldwide Development, Commercialization of Flurpiridaz F-18
News | Radiopharmaceuticals and Tracers| May 22, 2017
Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., and GE Healthcare announced the signing of a...
Sponsored Content | Videos | Atrial Fibrillation| May 17, 2017
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopk
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Sponsored Content | Videos | EP Lab| May 17, 2017
This video, provided by Spectranetics, demonstrates how to deploy the Bridge Occlusion Balloon used to seal accidenta
Spectranetics Bridge Occlusion Balloon in the SVC

An illustration of how the Bridge balloon can seal the SVC after an accidental tear from lead extration.

Feature | EP Lab| May 17, 2017 | Dave Fornell
May 17, 2017 — A new intravenous occlusion balloon designed to seal any accidental tears in the superior vena cava (S
Partners HealthCare and GE Healthcare Launch 10-year Collaboration on Artificial Intelligence
News | Artificial Intelligence| May 17, 2017
May 17, 2017 — Partners HealthCare and GE Healthcare announced a 10-year collaboration to rapidly develop, validate a
micra leadless pacemaker
Feature | Pacemakers| May 16, 2017
May 16, 2017 - The preliminary results for the Medtronic Micra Transcatheter Pacing System (TPS) Post-Approval Regist
Medtronic Reveal Linq implantable cardiac monitor

The Medtronic Reveal Linq implantable cardiac monitor is the smallest implantable monitor on the market. It is used as a long-term Holter monitor for 24-hour a day, 365-day a year patient monitoring. The device uses wireless connectivity to download the patient data with a patient bedside base unit to send the information over the internet so it is accessible by physicians.

Feature | Atrial Fibrillation| May 16, 2017
May 16, 2017 - The study using small, subcutaneous implantable cardiac monitors for long-term, 24-hour a day monitori
NewPace string subcutaneous ICD system

The NewPace string subcutaneous ICD system.

News | May 16, 2017
May 16, 2017 – A new study examines the effectiveness of the implantable subcutaneous string defibrillator (ISSDTM),
Overlay Init